Le salarié est le moteur de la rupture mobile dans l’entreprise
10/10/2012
More than $1 billion in 2012 digital health investments so far
10/10/2012

The 15 best-selling drugs of 2012 – FiercePharma

Some of the biggest blockbusters known to the pharma industry have dropped off the patent cliff and tumbled into the brutal land of generic therapies, where low-priced competition lays sales to waste. The once-mighty Lipitor is finished as a big earner, as we see in our new list of the 15 top-selling pharmaceuticals in 2012. In place of the small molecule standbys, biologics like Humira have risen to the top.

 

See on www.fiercepharma.com